# The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients

> **NCT02103049** · PHASE4 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 80 (actual)

## Conditions studied

- Dyslipidemia
- Transplants

## Interventions

- **DRUG:** Ezetimibe

## Key facts

- **NCT ID:** NCT02103049
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02103049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02103049, "The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02103049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*